3vrw: Difference between revisions

Revision as of 18:46, 2 May 2012

Unreleased structure

The entry 3vrw is ON HOLD

Authors: Yoshimoto, N., Inaba, Y., Itoh, T., Nakabayashi, M., Ito, N., Yamamoto, K.

Description: VDR ligand binding domain in complex with 22S-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin D3

Revision as of 08:40, 25 April 2012 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,330,058 edits m Protected "3vrw" [edit=sysop:move=sysop] ← Older edit		Revision as of 18:46, 2 May 2012 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,330,058 edits No edit summary Newer edit →
Line 5:		Line 5:
	Authors: Yoshimoto, N., Inaba, Y., Itoh, T., Nakabayashi, M., Ito, N., Yamamoto, K.		Authors: Yoshimoto, N., Inaba, Y., Itoh, T., Nakabayashi, M., Ito, N., Yamamoto, K.

	Description: VDR ligand binding domain in complex with 22S-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-~~1α~~,25-dihydroxyvitamin D3		Description: VDR ligand binding domain in complex with 22S-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin D3